AzTrials
AzTrials

Anterior Cruciate Ligament InjuriesNCT05068297

The Impact of Germanium-Embedded Knee Brace on Patient Recovery After ACL Reconstruction

A study testing Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction and Replica Knee Brace in people with Anterior Cruciate Ligament Injuries, run by Total Sports Medicine & Orthopedics.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Anti-inflammatory brace technology has demonstrated superior clinical outcomes in the management of knee osteoarthritis and accelerate recovery time for Major League Soccer players. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Anterior Cruciate Ligament Injuries
What is being tested?
Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction and Replica Knee Brace
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
Nov 2021to 1 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18-100 years old
  • Male or female
  • Compliant patient
  • BMI less than 35
  • Undergoing ACL reconstruction within 30 days

Who cannot join

  • Rheumatoid Arthritis
  • Poorly controlled diabetes (HgA1c > 7.5)
  • Previous blood clots
  • BMI greater than 35
  • Varicosities on operative leg

Trial locations and contacts

No sites are listed yet.

Shanthan C Challa, MD contact

7024998579

shanthancchalla@gmail.com

Roddy McGee contact

About this study

Official title: The Impact of Germanium-Embedded Knee Brace on Patient Recovery After ACL Reconstruction: a Blinded and Randomized Controlled Trial

Anti-inflammatory brace technology has demonstrated superior clinical outcomes in the management of knee osteoarthritis and accelerate recovery time for Major League Soccer players. Authors have postulated that embedding germanium into cotton garments increases circulation and augments the inflammatory process through a transdermal micro-electromagnetic field. In addition to immunomodulatory effects, knee braces immobilize and stabilize the joint through tactile feedback from the skin. Thus, a germanium-embedded knee brace may provide inflammatory control to augment pain and edema while concomitantly enhancing proprioception. ACL Reconstruction rehabilitation goals during the acute post-operative phase include diminishment of pain and edema as well as restoration of knee range-of-motion. The presented study intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction.

Single-center blinded randomized controlled clinical trial to study effectiveness of germanium-infused knee brace on rehabilitation in patient population undergoing ACL reconstruction. Patients will be randomized into germanium-infused knee brace group and compared to a replica knee brace group. Inclusion criteria will include skeletally mature individuals undergoing primary ACL reconstruction. Exclusion criteria will include autoimmune disorders and history of surgery on ipsilateral joint. The presented protocol intends to assess the impact of a germanium-embedded knee brace on patient recovery after ACL reconstruction. The primary outcome measure was chosen for its implications for the design and conduct of the study,1 including well-validated outcome instrument for comparison, facilitation of a priori power analysis, randomization, and blinding. Secondary outcomes were chosen for their pertinence to surgeon decision-making during patient rehabilitation.

Being tested
Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction, Replica Knee Brace
Medical subject headings
Anterior Cruciate Ligament Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Incrediwear Germanium-Embedded Knee Brace following ACL reconstructionOther

    Germanium-Embedded Knee Brace will be applied to the effected limb following ACL reconstruction

  • Replica Knee BraceOther

    Replica Knee brace will be applied to the effected limb following ACL reconstruction

Study groups in NCT05068297
Study groupRoleWhat they receive
Germanium-Embedded Knee BraceExperimentalFollowing surgery the patients effected limb would be placed in an Germanium-Embedded Knee Brace
Receives: Other: Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction
Replica Knee BraceActive comparatorFollowing surgery the patients effected limb would be placed in a replica knee brace
Receives: Other: Replica Knee Brace

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Short Form 36 (SF-36)

    A well-validated patient reported outcome and the most commonly used outcome instrument in orthopaedics.

    Measured: 4 weeks

Secondary outcomes (3)
  1. Pain Estimation

    Visual Analog Scale

    Measured: 6 weeks

  2. Leg Circumference

    In centimeters, measure by senior surgeon during physical exam using a tape measure at standard post-operative visits

    Measured: 6 weeks

  3. Knee Range of Motion

    In degrees, measured by a senior surgeon using a Goniometer, at standard post-operative visits

    Measured: 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2021
  2. Study startNov 2021 (estimated)
  3. Primary completion1 Sep 2022 (estimated)
  4. Study completion1 Oct 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05068297
Sponsor's protocol ID
IW001
Status last verified
Oct 2021
First submitted
19 Sep 2021
Last updated
25 Oct 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Incrediwear Germanium-Embedded Knee Brace following ACL reconstruction and Replica Knee Brace in people with Anterior Cruciate Ligament Injuries, run by Total Sports Medicine & Orthopedics.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shanthan C Challa, MD (7024998579, shanthancchalla@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Short Form 36 (SF-36) (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in